|Articles|January 11, 2022
- Pharmaceutical Executive-01-01-2022
- Volume 42
- Issue 1
Our View on 2022: Pharm Exec’s Annual Industry Outlook
Supply chain issues, psychedelic medicines, immunotherapies, social engagement, telemedicine, access barriers, corporate branding, and the rise of Chinese biotech are industry topics that deserve a closer look as we head into the future.
Advertisement
Follow the links below to read about each trend:
Articles in this issue
about 4 years ago
Keeping Tabs on Quality: The Rise of Digitalabout 4 years ago
China Invests in Building Biotechabout 4 years ago
Branding Takes on a New Lookabout 4 years ago
Addressing Access Burdensabout 4 years ago
Meeting the Patient—Virtuallyabout 4 years ago
The Age of Influenceabout 4 years ago
Boosting Immunotherapiesabout 4 years ago
Pharma’s Psychedelic Experienceabout 4 years ago
Supply Chain Procurementabout 4 years ago
Breaking New Ground in BiopharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts
2
WHO Finalizes United States’ Withdrawal from Organization: Report
3
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase: Report
4
Burnout and Shortages Put the Blood Supply at Risk
5